Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 9.27%7.52B | 9.94%24.7B | -1.12%6.03B | 35.27%6.88B | 7.59%22.46B | 5.37B | 13.25%5.91B | 11.50%6.1B | -1.10%5.09B | 1.49%20.88B |
| Cost of revenue | 11.57%5.04B | 6.81%15.93B | 1.64%3.96B | 35.42%4.51B | 5.30%14.91B | 3.74B | 10.45%3.94B | 4.61%3.89B | -4.48%3.33B | -2.59%14.16B |
| Gross profit | 4.90%2.49B | 16.11%8.77B | -5.99%2.07B | 34.97%2.37B | 12.43%7.55B | 1.62B | 19.31%1.97B | 26.19%2.2B | 6.03%1.76B | 11.31%6.72B |
| Operating expense | -4.38%921.7M | 13.70%3.86B | -7.11%929.65M | 28.60%963.94M | 14.16%3.4B | 823.74M | 9.69%822.91M | 32.24%1B | 4.27%749.57M | -0.50%2.98B |
| Staff costs | ---- | 9.22%1.84B | ---- | ---- | 13.68%1.68B | ---- | ---- | ---- | ---- | 0.77%1.48B |
| Selling and administrative expenses | ---- | 20.45%1.42B | ---- | ---- | 22.04%1.18B | ---- | ---- | ---- | ---- | -3.28%966.67M |
| -Selling and marketing expense | ---- | 8.22%277.94M | ---- | ---- | 16.72%256.84M | ---- | ---- | ---- | ---- | -16.46%220.04M |
| -General and administrative expense | ---- | 23.86%1.14B | ---- | ---- | 23.61%922.89M | ---- | ---- | ---- | ---- | 1.44%746.63M |
| Depreciation and amortization | ---- | -0.69%57.74M | ---- | ---- | -5.77%58.14M | ---- | ---- | ---- | ---- | 0.45%61.7M |
| -Depreciation | ---- | -0.69%57.74M | ---- | ---- | -5.77%58.14M | ---- | ---- | ---- | ---- | 0.45%61.7M |
| Rent and land expenses | ---- | 7.63%188.54M | ---- | ---- | -5.00%175.17M | ---- | ---- | ---- | ---- | -10.80%184.39M |
| Other operating expenses | ---- | 18.61%355.61M | ---- | ---- | 6.58%299.81M | ---- | ---- | ---- | ---- | 11.32%281.29M |
| Operating profit | 11.26%1.56B | 18.08%4.91B | -5.06%1.14B | 39.72%1.41B | 11.05%4.16B | 799.59M | 27.32%1.15B | 21.55%1.2B | 7.38%1.01B | 22.90%3.74B |
| Net non-operating interest income (expenses) | -72.58%-71.97M | -41.92%-204.1M | -42.58%-49.36M | -22.96%-41.7M | -12.70%-143.81M | -39.01M | -8.15%-36.27M | -13.61%-34.62M | -19.11%-33.91M | -25.82%-127.6M |
| Non-operating interest income | -40.00%12K | 413.33%154K | --6K | 42.86%20K | 57.89%30K | --0 | 45.45%16K | --0 | 100.00%14K | -99.75%19K |
| Non-operating interest expense | 72.53%71.98M | 42.00%204.25M | 42.60%49.36M | 22.97%41.72M | 12.71%143.84M | --39.01M | 8.16%36.29M | 13.61%34.62M | 19.13%33.93M | 17.22%127.62M |
| Net investment income | -138.02%-9.09M | 80.29%31.74M | 8.65%27.43M | 1,282.19%23.9M | -28.66%17.6M | -18.19M | -31.86%8.81M | 6.17%25.25M | -84.59%1.73M | 56.34%24.67M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 28.83M | -96.66%1.72M | 1.72M | 0 | -73.32%51.56M | 0 | 20.26%21.97M | 0 | 229.85%29.59M | 663.16%193.29M |
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -75.24%1.44M | -315.31%-126.36M | -199.96%-2.34M | 13.06%5.81M | -5.84%-30.43M | -41.89M | 133.05%3.98M | 766.19%2.35M | 62.61%5.14M | -101.89%-28.75M |
| Less:Other special charges | 75.24%-1.44M | 615.43%15.66M | 199.96%2.34M | -13.06%-5.81M | -121.55%-3.04M | --8.43M | -133.05%-3.98M | -766.19%-2.35M | -62.61%-5.14M | 100.80%14.11M |
| Less:Write off | ---- | 230.78%110.69M | ---- | ---- | 128.56%33.46M | ---- | ---- | ---- | ---- | -93.79%14.64M |
| Other non-operating income (expenses) | 122.60%11.52M | -288.34%-38.14M | -38.43%16.6M | -1,031.05%-50.95M | -65.37%20.25M | -14.68M | -80.35%2.51M | -25.81%26.95M | -72.05%5.47M | 284.75%58.47M |
| Income before tax | 13.55%1.52B | 12.30%4.57B | -7.10%1.14B | 32.41%1.34B | 5.40%4.07B | 685.82M | 27.66%1.15B | 18.33%1.22B | 6.59%1.01B | -14.55%3.86B |
| Income tax | -6.29%411.98M | 9.71%1.37B | -6.02%351.82M | 38.21%439.62M | 27.65%1.25B | 202.94M | 26.35%353.94M | 308.74%374.37M | 5.94%318.09M | -27.38%978.75M |
| Net income | 23.22%1.11B | 13.45%3.2B | -7.57%784.08M | 29.76%902.82M | -2.15%2.82B | 482.87M | 28.25%794.52M | -9.91%848.29M | 6.89%695.76M | -9.09%2.88B |
| Net income continuous operations | 23.22%1.11B | 13.45%3.2B | -7.57%784.08M | 29.76%902.82M | -2.15%2.82B | --482.87M | 28.25%794.52M | -9.91%848.29M | 6.89%695.76M | -9.09%2.88B |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 23.22%1.11B | 13.45%3.2B | -7.57%784.08M | 29.76%902.82M | -2.15%2.82B | 482.87M | 28.25%794.52M | -9.91%848.29M | 6.89%695.76M | -9.09%2.88B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 23.22%1.11B | 13.45%3.2B | -7.57%784.08M | 29.76%902.82M | -2.15%2.82B | 482.87M | 28.25%794.52M | -9.91%848.29M | 6.89%695.76M | -9.09%2.88B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 23.10%21.905 | 13.36%63.055 | -7.68%15.445 | 29.70%17.795 | -2.21%55.625 | 9.5175 | 28.21%15.6575 | -9.97%16.73 | 6.75%13.72 | -9.25%56.885 |
| Diluted earnings per share | 23.10%21.905 | 13.36%63.055 | -7.70%15.4402 | 29.70%17.795 | -2.21%55.625 | 9.5175 | 28.21%15.6575 | -9.98%16.7283 | 6.75%13.72 | -9.25%56.885 |
| Dividend per share | 0 | 32.84%22.25 | 9.75 | 0 | -2.90%16.75 | 16.75 | 0 | 0 | 0 | 46.81%17.25 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |